Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zealand Pharma A/S renews share buyback programme


Tuesday, 29 Apr 2014 12:33pm EDT 

Zealand Pharma A/S:Says the General Meeting granted the Board of Directors an authorization until the company‚Äôs next Annual General Meeting to acquire the company's own shares in a nominal amount of up to 10 pct of the company's share capital from time to time.The payment may not deviate from the share price quoted at NASDAQ OMX Copenhagen A/S at the time of purchase with more than 10 pct.